$ITCI
Intra-Cellular Therapies, Inc.

2015 Q1 Form 10-K Financial Statement

#000119312515089426 Filed on March 12, 2015

View on sec.gov

Income Statement

Concept 2015 Q1 2013 Q4 2013 Q3
Revenue $3.315K $827.5K $668.0K
YoY Change -98.02% 23.51% 76.75%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $3.770M $2.730M $1.300M
YoY Change 97.38% 143.75% 62.5%
% of Gross Profit
Research & Development $18.63M $6.130M $4.158M
YoY Change 558.55% 1078.85% 131.32%
% of Gross Profit
Depreciation & Amortization $15.24K $0.00 $4.729K
YoY Change 141.25% -100.0% -52.71%
% of Gross Profit
Operating Expenses $22.40M $8.860M $4.158M
YoY Change 691.86% 440.24% 131.32%
Operating Profit -$22.40M -$4.785M
YoY Change 389.69% 115.4%
Interest Expense $110.0K $10.00K $131.9K
YoY Change 2082.11% -105.56% 1218.88%
% of Operating Profit
Other Income/Expense, Net
YoY Change
Pretax Income -$22.29M -$8.020M -$4.910M
YoY Change 390.97% 597.39% 122.17%
Income Tax $0.00 $20.00K $0.00
% Of Pretax Income
Net Earnings -$22.29M -$8.041M -$4.912M
YoY Change 390.54% 593.17% 121.24%
Net Earnings / Revenue -672302.38% -971.66% -735.32%
Basic Earnings Per Share -$0.42
Diluted Earnings Per Share -$724.2K -$175.4K -$0.42
COMMON SHARES
Basic Shares Outstanding 34.93M shares 22.13M shares
Diluted Shares Outstanding

Balance Sheet

Concept 2015 Q1 2013 Q4 2013 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments $235.2M $37.20M $46.10M
YoY Change 61.54% 94.76%
Cash & Equivalents $100.8M $35.15M $44.07M
Short-Term Investments $134.4M $2.000M $2.000M
Other Short-Term Assets $1.300M $800.0K $800.0K
YoY Change 116.67% 300.0%
Inventory
Prepaid Expenses
Receivables $3.315K $336.3K $251.3K
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $236.5M $38.25M $47.13M
YoY Change 61.57% 94.81%
LONG-TERM ASSETS
Property, Plant & Equipment $559.7K $68.27K $75.70K
YoY Change 760.1% 17.17%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $70.94K $131.6K $130.8K
YoY Change -64.61% 0.61%
Total Long-Term Assets $630.7K $199.8K $206.5K
YoY Change 137.51% 5.72%
TOTAL ASSETS
Total Short-Term Assets $236.5M $38.25M $47.13M
Total Long-Term Assets $630.7K $199.8K $206.5K
Total Assets $237.1M $38.45M $47.34M
YoY Change 61.71% 93.96%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $4.574M $3.395M $4.027M
YoY Change 113.48% 8059.65%
Accrued Expenses $10.00M $3.400M $3.300M
YoY Change 455.56% 209.09%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $14.59M $6.834M $7.775M
YoY Change 273.06% 140.67%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $200.0K
YoY Change
Total Long-Term Liabilities $160.1K $0.00 $0.00
YoY Change
TOTAL LIABILITIES
Total Short-Term Liabilities $14.59M $6.834M $7.775M
Total Long-Term Liabilities $160.1K $0.00 $0.00
Total Liabilities $14.75M $6.800M $7.800M
YoY Change 278.28% 142.86%
SHAREHOLDERS EQUITY
Retained Earnings -$110.5M -$57.56M -$49.52M
YoY Change 77.99% 87.53%
Common Stock $333.0M $2.216K $2.213K
YoY Change 11394548.77% 51.78%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $222.4M $31.62M $39.56M
YoY Change
Total Liabilities & Shareholders Equity $237.1M $38.45M $47.34M
YoY Change 61.71% 93.96%

Cashflow Statement

Concept 2015 Q1 2013 Q4 2013 Q3
OPERATING ACTIVITIES
Net Income -$22.29M -$8.041M -$4.912M
YoY Change 390.54% 593.17% 121.24%
Depreciation, Depletion And Amortization $15.24K $0.00 $4.729K
YoY Change 141.25% -100.0% -52.71%
Cash From Operating Activities -$15.71M -$8.630M -$4.760M
YoY Change 125.07% 109.47% -14.85%
INVESTING ACTIVITIES
Capital Expenditures $520.4K $0.00 -$20.00K
YoY Change 16579.36% 100.0%
Acquisitions
YoY Change
Other Investing Activities -$66.18M $0.00 $0.00
YoY Change -100.0% -100.0%
Cash From Investing Activities -$66.70M $0.00 -$20.00K
YoY Change -100.0% -101.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $129.9M
YoY Change 11.8%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 121.9M -290.0K 40.52M
YoY Change 5.58% -101.91% 405100.0%
NET CHANGE
Cash From Operating Activities -15.71M -8.630M -4.760M
Cash From Investing Activities -66.70M 0.000 -20.00K
Cash From Financing Activities 121.9M -290.0K 40.52M
Net Change In Cash 39.48M -8.920M 35.74M
YoY Change -63.6% -175.53% -1030.73%
FREE CASH FLOW
Cash From Operating Activities -$15.71M -$8.630M -$4.760M
Capital Expenditures $520.4K $0.00 -$20.00K
Free Cash Flow -$16.23M -$8.630M -$4.740M
YoY Change 132.42% 109.47% -15.05%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
1400125 shares
CY2014Q2 dei Entity Public Float
EntityPublicFloat
240663855
CY2014Q3 us-gaap Business Acquisition Percentage Of Voting Interests Acquired
BusinessAcquisitionPercentageOfVotingInterestsAcquired
1.00 pure
CY2011Q4 us-gaap Stockholders Equity
StockholdersEquity
17892303
CY2011Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
13693215
CY2012Q4 us-gaap Stockholders Equity
StockholdersEquity
16984085
CY2012Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
15645528
CY2013Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
22159446 shares
CY2013Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
22159446 shares
CY2013Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2013Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
1.98
CY2013Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q1 us-gaap Share Price
SharePrice
17.50
CY2015Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34928424 shares
CY2013Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
0
CY2013Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
24787343
CY2013Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
3232003
CY2013Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
2611091
CY2013Q4 us-gaap Liabilities Current
LiabilitiesCurrent
6834037
CY2013Q4 us-gaap Common Stock Value
CommonStockValue
2216
CY2013Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3395067
CY2013Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-57564497
CY2013Q4 us-gaap Stockholders Equity
StockholdersEquity
31615275
CY2013Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
38449312
CY2013Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
89177556
CY2013Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1715904
CY2013Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
827879
CY2013Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
35150924
CY2013Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
0
CY2013Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
68272
CY2013Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
6000000
CY2013Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
2000000
CY2013Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
762243
CY2013Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
1874939
CY2013Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
3300275
CY2013Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
22346862
CY2013Q4 us-gaap Deferred Tax Assets In Process Research And Development
DeferredTaxAssetsInProcessResearchAndDevelopment
31891
CY2013Q4 us-gaap Assets
Assets
38449312
CY2013Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2013Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
336318
CY2013Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
2000000
CY2013Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
131555
CY2013Q4 us-gaap Assets Current
AssetsCurrent
38249485
CY2013Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
377049
CY2013Q4 itci Deferred Tax Assets Non Qualified Stock Options
DeferredTaxAssetsNonQualifiedStockOptions
53686
CY2013Q4 itci Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
-102916
CY2013Q4 itci Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
24787343
CY2014Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
29499059 shares
CY2014Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
29499059 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingNumber
2233460 shares
CY2014Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
100000000 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
9.20
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
1324552 shares
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
5.10
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Vested And Expected To Vest Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsVestedAndExpectedToVestOutstandingWeightedAverageExercisePrice
9.20
CY2014Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
2233460 shares
CY2014Q4 us-gaap Interest Payable Current And Noncurrent
InterestPayableCurrentAndNoncurrent
0
CY2014Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
39442661
CY2014Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
2228413
CY2014Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
7529241
CY2014Q4 us-gaap Liabilities Current
LiabilitiesCurrent
10557064
CY2014Q4 us-gaap Common Stock Value
CommonStockValue
2950
CY2014Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-104633
CY2014Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
2052765
CY2014Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-88255957
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Four Years
OperatingLeasesFutureMinimumPaymentsDueInFourYears
1210718
CY2014Q4 us-gaap Stockholders Equity
StockholdersEquity
120554705
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due
OperatingLeasesFutureMinimumPaymentsDue
13125243
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Five Years
OperatingLeasesFutureMinimumPaymentsDueInFiveYears
1247039
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Three Years
OperatingLeasesFutureMinimumPaymentsDueInThreeYears
1175454
CY2014Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
131111769
CY2014Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
208912345
CY2014Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
1717635
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due In Two Years
OperatingLeasesFutureMinimumPaymentsDueInTwoYears
1048661
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Gain Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedGainBeforeTax
1000
CY2014Q4 us-gaap Operating Leases Future Minimum Payments Due Current
OperatingLeasesFutureMinimumPaymentsDueCurrent
10630
CY2014Q4 us-gaap Common Stock Shares Subscriptions
CommonStockSharesSubscriptions
109833
CY2014Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
975058
CY2014Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
61325044
CY2014Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
9240467
CY2014Q4 us-gaap Money Market Funds At Carrying Value
MoneyMarketFundsAtCarryingValue
8500000
CY2014Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
54553
CY2014Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
18867087
CY2014Q4 us-gaap Assets Fair Value Disclosure Recurring
AssetsFairValueDisclosureRecurring
115815000
CY2014Q4 us-gaap Available For Sale Securities
AvailableForSaleSecurities
68320672
CY2014Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
1288953
CY2014Q4 us-gaap Available For Sale Securities Accumulated Gross Unrealized Loss Before Tax
AvailableForSaleSecuritiesAccumulatedGrossUnrealizedLossBeforeTax
106000
CY2014Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
2570540
CY2014Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
2282966
CY2014Q4 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
16625120
CY2014Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
34870169
CY2014Q4 us-gaap Assets
Assets
131111769
CY2014Q4 us-gaap Deferred Tax Assets Liabilities Net
DeferredTaxAssetsLiabilitiesNet
0
CY2014Q4 us-gaap Operating Loss Carryforwards
OperatingLossCarryforwards
78200000
CY2014Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
51603
CY2014Q4 us-gaap Available For Sale Securities Amortized Cost
AvailableForSaleSecuritiesAmortizedCost
68425000
CY2014Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
70944
CY2014Q4 us-gaap Assets Current
AssetsCurrent
130986272
CY2014Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Employee Benefits
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsEmployeeBenefits
443371
CY2014Q4 itci Operating Leases Future Minimum Payments Due In Six Years
OperatingLeasesFutureMinimumPaymentsDueInSixYears
8432741
CY2014Q4 itci Deferred Tax Assets Non Qualified Stock Options
DeferredTaxAssetsNonQualifiedStockOptions
1563785
CY2014Q4 itci Deferred Tax Liabilities Depreciation
DeferredTaxLiabilitiesDepreciation
5204
CY2014Q4 itci Deferred Tax Assets Liabilities Gross
DeferredTaxAssetsLiabilitiesGross
39442661
CY2014Q1 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
7063300 shares
CY2014Q1 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
115400000
CY2014Q1 itci Share Issued During Period Shares Underwriters New Issues
ShareIssuedDuringPeriodSharesUnderwritersNewIssues
921300 shares
CY2013 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0007 pure
CY2013 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-22591265
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y2M12D
CY2013 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.0658 pure
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.022 pure
CY2013 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
17260768 shares
CY2013 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.5037 pure
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y3M18D
CY2013 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.800 pure
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
1709255
CY2013 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.56
CY2013 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3500 pure
CY2013 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0372 pure
CY2013 us-gaap Operating Income Loss
OperatingIncomeLoss
-26266852
CY2013 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-26868198
CY2013 us-gaap Investment Income Interest
InvestmentIncomeInterest
29617
CY2013 us-gaap Interest Paid
InterestPaid
11320
CY2013 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
278000
CY2013 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
3754706
CY2013 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-13229355
CY2013 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0
CY2013 us-gaap License And Services Revenue
LicenseAndServicesRevenue
2737002
CY2013 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
574341
CY2013 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
332938
CY2013 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
35889
CY2013 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
391393
CY2013 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-13229355
CY2013 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1666674
CY2013 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
2785736
CY2013 us-gaap Interest Expense
InterestExpense
612963
CY2013 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
23027578
CY2013 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
19505396
CY2013 us-gaap Income Taxes Paid
IncomeTaxesPaid
31437
CY2013 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
6649
CY2013 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
701723
CY2013 us-gaap Revenues
Revenues
2737002
CY2013 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
33255
CY2013 us-gaap Net Income Loss
NetIncomeLoss
-26868198
CY2013 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
18000
CY2013 us-gaap Depreciation
Depreciation
23249
CY2013 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
40629916
CY2013 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
43841850
CY2013 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
77138
CY2013 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
1466745
CY2013 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
29003854
CY2013 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
332938
CY2013 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
18000
CY2013 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
827479
CY2013 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
100000
CY2013 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
1500000
CY2013 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
5976276
CY2013 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
3353459
CY2013 us-gaap Share Based Compensation
ShareBasedCompensation
391393
CY2013 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2013 itci Proceeds From Common Stock Subscribed
ProceedsFromCommonStockSubscribed
109834
CY2013 itci Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
-0.0120 pure
CY2014 us-gaap Interest Paid
InterestPaid
7073
CY2013 itci Effective Income Tax Rate Reconciliation Reserve For Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationReserveForUncertainTaxPositions
-0.0653 pure
CY2013 itci Stock Issued During Period Value Stock Subscription
StockIssuedDuringPeriodValueStockSubscription
109834
CY2013 itci Stock Issued During Period Value Issuance Of Common Stock Upon Private Placement
StockIssuedDuringPeriodValueIssuanceOfCommonStockUponPrivatePlacement
39963500
CY2013 itci Effective Income Tax Rate Reconciliation Return To Provision Research And Development Tax Credit Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionResearchAndDevelopmentTaxCreditPercent
0.0261 pure
CY2013 itci Effective Income Tax Rate Reconciliation State Income Tax Expense
EffectiveIncomeTaxRateReconciliationStateIncomeTaxExpense
0.1012 pure
CY2014 us-gaap Revenue Recognition Deferred Revenue
RevenueRecognitionDeferredRevenue
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Deferred Revenue</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Cash received as prepayment on future services is deferred and recognized as revenue as the services are performed. The Company must remit interest on any deferred revenue related to a governmental agency. As of December&#xA0;31, 2014 and 2013, no interest was due as the Company did not have any deferred revenue from a government agency.</p> </div>
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriod
1108000 shares
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
0.66
CY2014 dei Document Type
DocumentType
10-K
CY2014 dei Entity Registrant Name
EntityRegistrantName
Intra-Cellular Therapies, Inc.
CY2014 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2014 dei Trading Symbol
TradingSymbol
ITCI
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Grant Date Fair Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue
16.50
CY2014 dei Entity Filer Category
EntityFilerCategory
Accelerated Filer
CY2014 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2014 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.0001 pure
CY2014 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-22807150
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Expiration Period
SharebasedCompensationArrangementBySharebasedPaymentAwardExpirationPeriod
P10Y
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
CY2014 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.50 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
-0.0014 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.020 pure
CY2014 us-gaap Use Of Estimates
UseOfEstimates
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> <b>Use of Estimates</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> The preparation of financial statements in conformity with generally accepted accounting principles requires management to make estimates and assumptions that affect the amounts reported in the financial statements and accompanying notes. Although actual results could differ from those estimates, management does not believe that such differences would be material.</p> </div>
CY2014 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
28650067 shares
CY2014 dei Document Period End Date
DocumentPeriodEndDate
2014-12-31
CY2014 us-gaap Defined Contribution Plan Employer Matching Contribution Percent
DefinedContributionPlanEmployerMatchingContributionPercent
0.06 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.4775 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriodWeightedAverageExercisePrice
12.34
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P7Y3M18D
CY2014 dei Amendment Flag
AmendmentFlag
false
CY2014 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2014 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2014
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Weighted Average Remaining Contractual Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableWeightedAverageRemainingContractualTerm1
P5Y10M24D
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Forfeitures And Expirations In Period
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsForfeituresAndExpirationsInPeriod
27500 shares
CY2014 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
16.50
CY2013Q3 us-gaap Net Income Loss
NetIncomeLoss
-4911620
CY2014Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.22
CY2014Q3 us-gaap Revenues
Revenues
124414
CY2014Q3 us-gaap Net Income Loss
NetIncomeLoss
-6415507
CY2014 dei Entity Central Index Key
EntityCentralIndexKey
0001567514
CY2014 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-1.07
CY2014 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.3500 pure
CY2014 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.0232 pure
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.800 pure
CY2014 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2014 us-gaap Concentration Risk Credit Risk
ConcentrationRiskCreditRisk
<div> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 18pt"> <b>Concentration of Credit Risk</b></p> <p style="MARGIN-BOTTOM: 0pt; FONT-SIZE: 10pt; FONT-FAMILY: Times New Roman; MARGIN-TOP: 6pt"> Cash equivalents are held with major financial institutions in the United States. Certificates of deposit held with banks may exceed the amount of insurance provided on such deposits. Generally, these deposits may be redeemed upon demand and, therefore, bear minimal risk.</p> </div>
CY2014Q1 us-gaap Net Income Loss
NetIncomeLoss
-4543284
CY2013Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.56
CY2013Q2 us-gaap Revenues
Revenues
643264
CY2013Q2 us-gaap Net Income Loss
NetIncomeLoss
-8277391
CY2014Q2 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.15
CY2014Q2 us-gaap Revenues
Revenues
219238
CY2014Q2 us-gaap Net Income Loss
NetIncomeLoss
-4533539
CY2013Q3 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.28
CY2013Q3 us-gaap Revenues
Revenues
667955
CY2014 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
26174120
CY2014 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1600
CY2014 us-gaap Depreciation
Depreciation
25481
CY2014 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
115715560
CY2014 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
247165 shares
CY2014 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2014 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
115442747
CY2014 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
3703000
CY2014 us-gaap Revenue From Grants
RevenueFromGrants
29755
CY2014 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
748538
CY2014 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-297223
CY2014 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
-14655320
CY2014 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
103601836
CY2014 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-104633
CY2014 us-gaap Excess Tax Benefit From Share Based Compensation Operating Activities
ExcessTaxBenefitFromShareBasedCompensationOperatingActivities
0
CY2014 us-gaap Unrealized Gain Loss On Investments
UnrealizedGainLossOnInvestments
-104633
CY2014 us-gaap License And Services Revenue
LicenseAndServicesRevenue
547546
CY2014 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
466099
CY2014 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
162980
CY2014 us-gaap Operating Income Loss
OperatingIncomeLoss
-30986723
CY2014 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-30796093
CY2014 us-gaap Income Taxes Paid
IncomeTaxesPaid
44998
CY2014 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1731
CY2014 us-gaap Revenues
Revenues
577301
CY2014 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
11762
CY2014 us-gaap Net Income Loss
NetIncomeLoss
-30691460
CY2014 us-gaap Investment Income Interest
InvestmentIncomeInterest
303936
CY2014 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
116191285
CY2014 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
84757
CY2014 us-gaap Issuance Of Stock And Warrants For Services Or Claims
IssuanceOfStockAndWarrantsForServicesOrClaims
176085
CY2014 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
-66734290
CY2014 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-284715
CY2014 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
3843878
CY2014 us-gaap Adjustments To Additional Paid In Capital Tax Effect From Share Based Compensation
AdjustmentsToAdditionalPaidInCapitalTaxEffectFromShareBasedCompensation
1500000
CY2014 us-gaap Stock Issued During Period Value Issued For Services
StockIssuedDuringPeriodValueIssuedForServices
176085
CY2014 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-14655320
CY2014 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
5065329
CY2014 us-gaap Interest Expense
InterestExpense
7073
CY2014 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
21226345
CY2014 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
31564024
CY2014 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
162980
CY2014 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
1600
CY2014 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
853504
CY2014 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
36879308
CY2014 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
10337679
CY2014 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-1342302
CY2014 us-gaap Share Based Compensation
ShareBasedCompensation
3843878
CY2014 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercises In Period Total Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue
3696775
CY2014 us-gaap Impairment Of Long Lived Assets Held For Use
ImpairmentOfLongLivedAssetsHeldForUse
0
CY2014 itci Percentage Of Dividend Rate
PercentageOfDividendRate
0.00 pure
CY2014 itci Federal Net Operating Loss Carry Forward Expiration Period
FederalNetOperatingLossCarryForwardExpirationPeriod
2034
CY2014 itci Maximum Maturity Period Of Marketable Securities
MaximumMaturityPeriodOfMarketableSecurities
P12M
CY2014 itci Proceeds From Common Stock Subscribed
ProceedsFromCommonStockSubscribed
109833
CY2014 itci Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageRemainingContractualTerm
P6M
CY2014 itci Effective Income Tax Rate Reconciliation Permanent Differences
EffectiveIncomeTaxRateReconciliationPermanentDifferences
0.0012 pure
CY2014 itci Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Weighted Average Remaining Contractual Term2
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageRemainingContractualTerm2
P9Y6M
CY2014 itci Effective Income Tax Rate Reconciliation Reserve For Uncertain Tax Positions
EffectiveIncomeTaxRateReconciliationReserveForUncertainTaxPositions
-0.0001 pure
CY2014 itci Available For Sale Securities Maturity Period
AvailableForSaleSecuritiesMaturityPeriod
More than three months
CY2014 itci Maturity Period Of Liquid Investments To Be Considered As Cash Equivalents
MaturityPeriodOfLiquidInvestmentsToBeConsideredAsCashEquivalents
Three months or less
CY2014 itci Effective Income Tax Rate Reconciliation Return To Provision Research And Development Tax Credit Percent
EffectiveIncomeTaxRateReconciliationReturnToProvisionResearchAndDevelopmentTaxCreditPercent
-0.0005 pure
CY2014 itci Share Based Compensation Arrangement By Share Based Payment Award Canceled Weighted Average Remaining Contractual Term
ShareBasedCompensationArrangementByShareBasedPaymentAwardCanceledWeightedAverageRemainingContractualTerm
P6Y10M24D
CY2014 itci Effective Income Tax Rate Reconciliation State Income Tax Expense
EffectiveIncomeTaxRateReconciliationStateIncomeTaxExpense
0.1050 pure
CY2012 us-gaap Net Cash Provided By Used In Operating Activities Continuing Operations
NetCashProvidedByUsedInOperatingActivitiesContinuingOperations
-18902937
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0.00 pure
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Fair Value Assumptions Expected Term1
SharebasedCompensationArrangementBySharebasedPaymentAwardFairValueAssumptionsExpectedTerm1
P6Y3M18D
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRate
0.012 pure
CY2012 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
5607539 shares
CY2012 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.96
CY2012 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRate
0.797 pure
CY2012 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested In Period Fair Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedInPeriodFairValue1
332000
CY2012 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
12000000
CY2012 us-gaap License And Services Revenue
LicenseAndServicesRevenue
3117991
CY2012 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
34189
CY2012 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
31081
CY2012 us-gaap Operating Income Loss
OperatingIncomeLoss
-16403410
CY2012 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-16590827
CY2012 us-gaap Income Taxes Paid
IncomeTaxesPaid
13857
CY2012 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
15356422
CY2012 us-gaap Revenues
Revenues
3117991
CY2012 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
38957
CY2012 us-gaap Net Income Loss
NetIncomeLoss
-16590827
CY2012 us-gaap Investment Income Interest
InvestmentIncomeInterest
39002
CY2012 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
-48634
CY2012 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
295106
CY2012 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-1666659
CY2012 us-gaap Increase Decrease In Employee Related Liabilities
IncreaseDecreaseInEmployeeRelatedLiabilities
-448493
CY2012 us-gaap Interest Expense
InterestExpense
193498
CY2012 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
15486476
CY2012 us-gaap Cash And Cash Equivalents Period Increase Decrease
CashAndCashEquivalentsPeriodIncreaseDecrease
1952313
CY2012 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
32921
CY2012 us-gaap Depreciation
Depreciation
47747
CY2012 us-gaap Net Cash Provided By Used In Financing Activities Continuing Operations
NetCashProvidedByUsedInFinancingActivitiesContinuingOperations
15194085
CY2012 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
79656
CY2012 us-gaap Net Cash Provided By Used In Investing Activities Continuing Operations
NetCashProvidedByUsedInInvestingActivitiesContinuingOperations
5661165
CY2012 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
19521401
CY2012 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
31081
CY2012 us-gaap Lease And Rental Expense
LeaseAndRentalExpense
809332
CY2012 us-gaap Proceeds From Convertible Debt
ProceedsFromConvertibleDebt
15163004
CY2012 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
17700122
CY2012 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
4034925
CY2012 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-554256
CY2012 us-gaap Share Based Compensation
ShareBasedCompensation
295106
CY2013Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.39
CY2013Q1 us-gaap Revenues
Revenues
598252
CY2013Q1 us-gaap Net Income Loss
NetIncomeLoss
-5638377
CY2014Q1 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.17
CY2014Q1 us-gaap Revenues
Revenues
167787
CY2013Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.36
CY2013Q4 us-gaap Revenues
Revenues
827531
CY2013Q4 us-gaap Net Income Loss
NetIncomeLoss
-8040810
CY2014Q4 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-0.52
CY2014Q4 us-gaap Revenues
Revenues
65862
CY2014Q4 us-gaap Net Income Loss
NetIncomeLoss
-15199130

Files In Submission

Name View Source Status
0001193125-15-089426-index-headers.html Edgar Link pending
0001193125-15-089426-index.html Edgar Link pending
0001193125-15-089426.txt Edgar Link pending
0001193125-15-089426-xbrl.zip Edgar Link pending
d857051d10k.htm Edgar Link pending
d857051dex1011.htm Edgar Link pending
d857051dex1022.htm Edgar Link pending
d857051dex231.htm Edgar Link pending
d857051dex311.htm Edgar Link pending
d857051dex312.htm Edgar Link pending
d857051dex321.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xls Edgar Link pending
Financial_Report.xlsx Edgar Link pending
g857051g47r12.jpg Edgar Link pending
itci-20141231.xml Edgar Link completed
itci-20141231.xsd Edgar Link pending
itci-20141231_cal.xml Edgar Link unprocessable
itci-20141231_def.xml Edgar Link unprocessable
itci-20141231_lab.xml Edgar Link unprocessable
itci-20141231_pre.xml Edgar Link unprocessable
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending